<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font25 { font-size : 25; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font25">the </span>
   <span class="font17">for </span>
   <span class="font14">COVID- </span>
   <span class="font14">with </span>
   <span class="font13">patients </span>
   <span class="font13">are </span>
   <span class="font12">Phase </span>
   <span class="font12">clinical </span>
   <span class="font12">viral </span>
   <span class="font12">[]. </span>
   <span class="font12">has </span>
   <span class="font11">have </span>
   <span class="font11">treatment </span>
   <span class="font11">SARS-CoV- </span>
   <span class="font11">drugs </span>
   <span class="font11">that </span>
   <span class="font11">{background </span>
   <span class="font11">coronavirus </span>
   <span class="font11">COVID-. </span>
   <span class="font11">trials </span>
   <span class="font11">The </span>
   <span class="font11">antiviral </span>
   <span class="font11">efficacy </span>
   <span class="font11">respiratory </span>
   <span class="font11">against </span>
   <span class="font11">therapy </span>
   <span class="font11">RNA </span>
   <span class="font11">also </span>
   <span class="font11">severe </span>
   <span class="font11">al. </span>
   <span class="font11">cells </span>
   <span class="font11">drug </span>
   <span class="font11">margin </span>
   <span class="font11">trial </span>
   <span class="font11">Target </span>
   <span class="font11">acute </span>
   <span class="font11">{border-style </span>
   <span class="font11">its </span>
   <span class="font11">more </span>
   <span class="font11">virus </span>
   <span class="font10">disease </span>
   <span class="font10">from </span>
   <span class="font10">px;} </span>
   <span class="font10">receptor </span>
   <span class="font10">remdesivir </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">cell </span>
   <span class="font10">lung </span>
   <span class="font10">potential </span>
   <span class="font10">shown </span>
   <span class="font10">studies </span>
   <span class="font10">this </span>
   <span class="font10">was </span>
   <span class="font10">being </span>
   <span class="font10">cytokine </span>
   <span class="font10">inhibits </span>
   <span class="font10">many </span>
   <span class="font10">might </span>
   <span class="font10">reported </span>
   <span class="font10">role </span>
   <span class="font10">used </span>
   <span class="font10">Med </span>
   <span class="font10">human </span>
   <span class="font10">natural </span>
   <span class="font10">protease </span>
   <span class="font10">protein </span>
   <span class="font10">study </span>
   <span class="font10">various </span>
   <span class="font10">China </span>
   <span class="font10">been </span>
   <span class="font10">group </span>
   <span class="font10">other </span>
   <span class="font10">patients. </span>
   <span class="font10">use </span>
   <span class="font10">which </span>
   <span class="font10">Also, </span>
   <span class="font10">HCQ </span>
   <span class="font10">including </span>
   <span class="font10">novel </span>
   <span class="font10">such </span>
   <span class="font10">syndrome </span>
   <span class="font10">their </span>
   <span class="font10">therapeutic </span>
   <span class="font10">infection </span>
   <span class="font10">vaccines </span>
   <span class="font10">Chinese </span>
   <span class="font10">Engl </span>
   <span class="font10">IL- </span>
   <span class="font10">associated </span>
   <span class="font10">control </span>
   <span class="font10">development </span>
   <span class="font10">inhibitor) </span>
   <span class="font10">like </span>
   <span class="font10">medicines </span>
   <span class="font10">studied </span>
   <span class="font10">than </span>
   <span class="font10">favipiravir </span>
   <span class="font10">inhibit </span>
   <span class="font10">not </span>
   <span class="font10">(antiviral, </span>
   <span class="font10">However, </span>
   <span class="font10">Recently, </span>
   <span class="font10">activity </span>
   <span class="font10">cytokines </span>
   <span class="font10">herbal </span>
   <span class="font10">influenza </span>
   <span class="font10">monoclonal </span>
   <span class="font10">pandemic </span>
   <span class="font10">phase </span>
   <span class="font10">plasma </span>
   <span class="font10">pneumonia </span>
   <span class="font10">products </span>
   <span class="font10">reduce </span>
   <span class="font10">stem </span>
   <span class="font10">storm </span>
   <span class="font10">thereby </span>
   <span class="font10">Approved </span>
   <span class="font10">Investigational </span>
   <span class="font10">TCM </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">antibodies </span>
   <span class="font10">any </span>
   <span class="font10">combination </span>
   <span class="font10">conducted </span>
   <span class="font10">current </span>
   <span class="font10">immune </span>
   <span class="font10">immunomodulatory </span>
   <span class="font10">inflammation </span>
   <span class="font10">inflammatory </span>
   <span class="font10">injury </span>
   <span class="font10">killer </span>
   <span class="font10">most </span>
   <span class="font10">promising </span>
   <span class="font10">px; </span>
   <span class="font10">registered </span>
   <span class="font10">replication </span>
   <span class="font10">results </span>
   <span class="font10">review </span>
   <span class="font10">some </span>
   <span class="font10">traditional </span>
   <span class="font10">type </span>
   <span class="font10">{font-family </span>
   <span class="font10">ACE </span>
   <span class="font10">COVID-: </span>
   <span class="font10">LPV/RTV </span>
   <span class="font10">Natural </span>
   <span class="font10">after </span>
   <span class="font10">alone </span>
   <span class="font10">both </span>
   <span class="font10">comparison </span>
   <span class="font10">compounds </span>
   <span class="font10">convalescent </span>
   <span class="font10">font-size </span>
   <span class="font10">improvement </span>
   <span class="font10">mesenchymal </span>
   <span class="font10">need </span>
   <span class="font10">prevent </span>
   <span class="font10">prevents </span>
   <span class="font10">these </span>
   <span class="font10">time </span>
   <span class="font10">will </span>
   <span class="font10">ARDS </span>
   <span class="font10">Ayurvedic </span>
   <span class="font10">COVID-, </span>
   <span class="font10">Clinical </span>
   <span class="font10">Health </span>
   <span class="font10">Immunol </span>
   <span class="font10">JAK </span>
   <span class="font10">Moreover, </span>
   <span class="font10">RdRp </span>
   <span class="font10">Targets </span>
   <span class="font10">These </span>
   <span class="font10">This </span>
   <span class="font10">WHO </span>
   <span class="font10">Wang </span>
   <span class="font10">angiotensin </span>
   <span class="font10">animal </span>
   <span class="font10">combat </span>
   <span class="font10">death </span>
   <span class="font10">develop </span>
   <span class="font10">distress </span>
   <span class="font10">double; </span>
   <span class="font10">into </span>
   <span class="font10">open-label </span>
   <span class="font10">randomized </span>
   <span class="font10">randomized, </span>
   <span class="font10">reduces </span>
   <span class="font10">release </span>
   <span class="font10">safety </span>
   <span class="font10">should </span>
   <span class="font10">standard </span>
   <span class="font10">targets </span>
   <span class="font10">therapies </span>
   <span class="font10">they </span>
   <span class="font10">yet </span>
   <span class="font10">:â€". </span>
   <span class="font10">;./.... </span>
   <span class="font10">Available </span>
   <span class="font10">Chen </span>
   <span class="font10">China, </span>
   <span class="font10">Ebola </span>
   <span class="font10">Favipiravir </span>
   <span class="font10">July </span>
   <span class="font10">Med. </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">Several </span>
   <span class="font10">[â€"]. </span>
   <span class="font10">act </span>
   <span class="font10">action </span>
   <span class="font10">adequate </span>
   <span class="font10">agents </span>
   <span class="font10">analog) </span>
   <span class="font10">approved </span>
   <span class="font10">article </span>
   <span class="font10">available </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">but </span>
   <span class="font10">can </span>
   <span class="font10">cellular </span>
   <span class="font10">chronic </span>
   <span class="font10">could </span>
   <span class="font10">data </span>
   <span class="font10">demonstrated </span>
   <span class="font10">developed </span>
   <span class="font10">early </span>
   <span class="font10">effect </span>
   <span class="font10">effects </span>
   <span class="font10">enzyme </span>
   <span class="font10">health </span>
   <span class="font10">hepatitis </span>
   <span class="font10">highly </span>
   <span class="font10">hospitalized </span>
   <span class="font10">immunity </span>
   <span class="font10">immunomodulators, </span>
   <span class="font10">increase </span>
   <span class="font10">infections. </span>
   <span class="font10">inhibitor </span>
   <span class="font10">inhibitors </span>
   <span class="font10">major </span>
   <span class="font10">medicine </span>
   <span class="font10">mortality </span>
   <span class="font10">only </span>
   <span class="font10">patients, </span>
   <span class="font10">people </span>
   <span class="font10">polymerase </span>
   <span class="font10">recent </span>
   <span class="font10">search </span>
   <span class="font10">severity </span>
   <span class="font10">solid; </span>
   <span class="font10">specific </span>
   <span class="font10">spread </span>
   <span class="font10">strategies </span>
   <span class="font10">targeting </span>
   <span class="font10">tocilizumab </span>
   <span class="font10">trial. </span>
   <span class="font10">trials. </span>
   <span class="font10">under </span>
   <span class="font10">vaccine </span>
   <span class="font10">viruses </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(recombinant </span>
   <span class="font10">-nCoV </span>
   <span class="font10">After </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">FDA </span>
   <span class="font10">Hydroxychloroquine </span>
   <span class="font10">IL-, </span>
   <span class="font10">Infect </span>
   <span class="font10">Many </span>
   <span class="font10">Research </span>
   <span class="font10">Rheumatoid </span>
   <span class="font10">SARS </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">Sci </span>
   <span class="font10">So, </span>
   <span class="font10">Table </span>
   <span class="font10">Therapies </span>
   <span class="font10">They </span>
   <span class="font10">Wuhan, </span>
   <span class="font10">Zhang </span>
   <span class="font10">acts </span>
   <span class="font10">adverse </span>
   <span class="font10">among </span>
   <span class="font10">arthritis </span>
   <span class="font10">arthritis, </span>
   <span class="font10">beneficial </span>
   <span class="font10">binding </span>
   <span class="font10">blocking </span>
   <span class="font10">bold </span>
   <span class="font10">chloroquine </span>
   <span class="font10">courier; </span>
   <span class="font10">daily </span>
   <span class="font10">date, </span>
   <span class="font10">day </span>
   <span class="font10">difference </span>
   <span class="font10">dose </span>
   <span class="font10">double-blind, </span>
   <span class="font10">drugs, </span>
   <span class="font10">em; </span>
   <span class="font10">emerging </span>
   <span class="font10">enzyme, </span>
   <span class="font10">established </span>
   <span class="font10">failure </span>
   <span class="font10">fusion </span>
   <span class="font10">global </span>
   <span class="font10">help </span>
   <span class="font10">host </span>
   <span class="font10">ill </span>
   <span class="font10">important </span>
   <span class="font10">infection. </span>
   <span class="font10">inhibiting </span>
   <span class="font10">inhibition </span>
   <span class="font10">innate </span>
   <span class="font10">interventions </span>
   <span class="font10">involved </span>
   <span class="font10">known </span>
   <span class="font10">larger </span>
   <span class="font10">lead </span>
   <span class="font10">less </span>
   <span class="font10">load </span>
   <span class="font10">medRxiv. </span>
   <span class="font10">medicinal </span>
   <span class="font10">needed </span>
   <span class="font10">nucleoside </span>
   <span class="font10">ongoing </span>
   <span class="font10">outcome </span>
   <span class="font10">outcomes </span>
   <span class="font10">pandemic. </span>
   <span class="font10">pipeline </span>
   <span class="font10">plus </span>
   <span class="font10">possible </span>
   <span class="font10">preventing </span>
   <span class="font10">production </span>
   <span class="font10">proinflammatory </span>
   <span class="font10">prophylaxis </span>
   <span class="font10">proposed </span>
   <span class="font10">pt;} </span>
   <span class="font10">published </span>
   <span class="font10">recovery </span>
   <span class="font10">reducing </span>
   <span class="font10">required </span>
   <span class="font10">symptoms </span>
   <span class="font10">synthesis </span>
   <span class="font10">targeted </span>
   <span class="font10">there </span>
   <span class="font10">treat </span>
   <span class="font10">using </span>
   <span class="font10">via </span>
   <span class="font10">were </span>
  </p>
 </body>
</html>
